UPDATE: Medtronic FQ1 Profit Beats Street View

Loading...
Loading...
Medtronic
MDT
reported better-than-expected fiscal first-quarter earnings. The Minneapolis, Minnesota-based company posted a quarterly profit of $871 million, or $0.87 per share, versus a year-ago profit of $953 million, or $0.93 per share. Excluding non-recurring items, Medtronic's adjusted earnings came in at $0.93 per share. Its sales climbed 4% to $4.27 billion. However, analysts were expecting earnings of $0.92 per share on revenue of $4.25 billion. Medtronic's US revenue rose 6% to $2.333 billion, while international revenue climbed 2% to $1.940 billion on a constant currency basis. Emerging market revenue jumped 11% to $539 million on a constant currency basis. Sales at the Cardiac and Vascular Group surged 4% to $2.254 billion, while sales at the Restorative Therapies Group climbed 3% to $1.603 billion. Diabetes revenue jumped 13% to $416 million in the quarter. Omar Ishrak, Medtronic chairman and chief executive officer said, "Our growth was broad based across businesses and geographies. I was especially pleased that our innovation pipeline is delivering strong results, particularly in the U.S., which had its highest revenue growth performance in 5 years." Medtronic reiterated its EPS and revenue forecast for fiscal year 2015. Medtronic shares gained 0.35% to close at $63.47 yesterday.
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: EarningsNewsGuidanceprofit
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...